UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars
new
Gut Guide online
Visit ueg.eu Create myUEG account Log In
Visit ueg.eu Create myUEG account Log In

Filters:

UEG Online Course
not accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Gastrointestinal Neuroendocrine Tumours

Dalvinder Mandair, Christos Toumpanakis, Martyn E Caplin

Summary

AI Generated

This online course covers the classification, diagnosis, staging, and management of gastric, duodenal, and rectal neuroendocrine tumours, which are increasingly detected during endoscopy despite being rare.

  • Neuroendocrine tumours develop from enterochromaffin cells throughout the gastrointestinal tract, with most arising in the gastro-entero-pancreatic tract
  • Although rare, the incidence of NETs is increasing and their prevalence is high due to prolonged patient survival
  • Prognosis and treatment options vary according to tumour size, grade/stage, and functionality, making correct diagnosis and staging key
  • The course teaches recognition of endoscopic features indicating NETs, required diagnostic investigations, classification systems, and identification of patients requiring specialist centre referral
  • The course is designed for gastroenterologists, nurse endoscopists, gastrointestinal and colorectal surgeons, as well as trainees and medical students
Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

Neuroendocrine tumours (NETs) develop from enterochromaffin cells, which are located throughout the gastrointestinal tract. Most NETs arise in the gastro-entero-pancreatic tract (GEP-NETs) and they are increasingly found during endoscopic investigation. Although rare, the incidence of NETs is increasing, and prolonged patient survival means that their prevalence is high. Prognosis and treatment options vary according to the size, grade/stage and functionality of the NET, making correct diagnosis and staging key.

In this online course, Dalvinder Mandair, Christos Toumpanakis and Martyn Caplin cover all aspects of gastric NETs, duodenal NETs and rectal NETs—their pathogenesis, investigation, diagnosis, classification, staging, management and prognosis.  

Learning objectives

  • To develop an understanding of the classification of gastric, duodenal and rectal neuroendocrine tumours (NETs)
  • To recognise the endoscopic features that may indicate the presence of a NET
  • To learn which investigations are required as part of the diagnostic work-up
  • To identify the patients that need to be referred to a specialist NET centre

Target audience

This course is suitable for gastroenterologists, nurse endoscopists, upper gastrointestinal surgeons and colorectal surgeons, but is also appropriate for trainees and medical students.

Event

Gastrointestinal Neuroendocrine Tumours

Topics

Digestive Oncology

Accreditation status

not accredited

Duration

1 hour

Published

2019

More Like This:

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Leigh Donnelly Leigh Donnelly, Mary Phillips

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

Lumir Kunovsky Lumir Kunovsky, Alberto Zanetto, Jonas J. Staudacher, Sophie Schlosser-Hupf, Lucas Wauters, Andrei Mihai Voiosu, Katja Tepeš, Milica Stojkovic Lalosevic, Paula Sousa, Cem Simsek, Orestis Sidiropoulos, Maciej Salaga, Hasan Sadigov, Odri Qejvani, Anthea Pisani, Gianluca Pellino, Hassan Ouaya, Yana Nikiforova, Maria Moris, Mattias Mandorfer, Jan Král, Iris J. M. Levink, Henriette Heinrich, Ismar Hasukic, Valon Hamza, Amer Hadi, Zornitsa Gorcheva, Mark Enrik Geissler, Anne Fennessy, Omar Elshaarawy, Martin Ďuriček, Ana Dugic, Viktor Domislovic, Egle Dieninyte - Misiune, Helena Tammela, Myriam Ayari, Pilar Acedo, Marcus Hollenbach, Stavros Dimitriadis, Oscar Cahyadi, Karim Hamesch

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

Miguel Mascarenhas-Saraiva Miguel Mascarenhas-Saraiva, Rui Tato Marinho, Carina Leal, Joana Revés, Bárbara Morão, Joao Paulo Laranjeira Correia, João Carlos Silva, Paulo Souto, Mara Costa, Silvia Maria Barrias, Tiago Guedes, Helena Coelho Lima, Raquel R. Mendes, Jose Azevedo Rodrigues, André Mascarenhas

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

Gabriele Capurso Gabriele Capurso, Paolo Giorgio Arcidiacono, Caterina Stornello, Niccolò Bina, Camilla Gallo, Sara Massironi, Matteo Tacelli

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

Braden Kuo Braden Kuo, Artemis Trikola, Kyle Staller, Benjamin Glickman, Nir Bar

UEG Online Course
accredited
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Management of early-invasive (T1) colorectal cancer

Alexandra Langers, Jurjen J. Boonstra, James Hardwick

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Overview

With the introduction of population-based screening programs in several countries, the proportion of patients diagnosed with early invasive colorectal cancer (T1 CRC) has been vastly increasing. There are several major challenges in clinical management of this patient group, resulting in significant practice variations among physicians.

This online course covers the most relevant aspects of clinical management of T1 CRC patients, and provides an overview of latest insights and current knowledge gaps. To facilitate the learning process, several questions on real-life patient cases have been included in which learners can bring the acquired knowledge directly into practice.

Learning objectives

  • To systematically assess colorectal lesions and identify those suspicious for submucosally invasive (T1) cancer
  • To learn about local resection techniques for T1 colorectal cancer
  • To gain insight into histological assessment of local en bloc resection specimens of T1 colorectal cancer
  • To be aware of considerations from the oncological and patient perspective in therapeutic decision making after local treatment for T1 colorectal cancer

Target audience

This course is suitable for gastroenterologists, surgeons, pathologists, nurses and any other healthcare professionals interested in, or actively involved in clinical management of T1 CRC patients. 

This course was developed by Alexandra M.J. Langers, Jurjen J. Boonstra, James C.H. Hardwick, Richard (H.) Dang et al. in receipt of an Activity Grant from UEG.

Reviewed & updated December 2022

Event

Management of early-invasive (T1) colorectal cancer

Topics

Digestive Oncology

Accreditation status

accredited

Duration

1 hour

Published

2020

More Like This:

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Leigh Donnelly Leigh Donnelly, Mary Phillips

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

Lumir Kunovsky Lumir Kunovsky, Alberto Zanetto, Jonas J. Staudacher, Sophie Schlosser-Hupf, Lucas Wauters, Andrei Mihai Voiosu, Katja Tepeš, Milica Stojkovic Lalosevic, Paula Sousa, Cem Simsek, Orestis Sidiropoulos, Maciej Salaga, Hasan Sadigov, Odri Qejvani, Anthea Pisani, Gianluca Pellino, Hassan Ouaya, Yana Nikiforova, Maria Moris, Mattias Mandorfer, Jan Král, Iris J. M. Levink, Henriette Heinrich, Ismar Hasukic, Valon Hamza, Amer Hadi, Zornitsa Gorcheva, Mark Enrik Geissler, Anne Fennessy, Omar Elshaarawy, Martin Ďuriček, Ana Dugic, Viktor Domislovic, Egle Dieninyte - Misiune, Helena Tammela, Myriam Ayari, Pilar Acedo, Marcus Hollenbach, Stavros Dimitriadis, Oscar Cahyadi, Karim Hamesch

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

Miguel Mascarenhas-Saraiva Miguel Mascarenhas-Saraiva, Rui Tato Marinho, Carina Leal, Joana Revés, Bárbara Morão, Joao Paulo Laranjeira Correia, João Carlos Silva, Paulo Souto, Mara Costa, Silvia Maria Barrias, Tiago Guedes, Helena Coelho Lima, Raquel R. Mendes, Jose Azevedo Rodrigues, André Mascarenhas

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

Gabriele Capurso Gabriele Capurso, Paolo Giorgio Arcidiacono, Caterina Stornello, Niccolò Bina, Camilla Gallo, Sara Massironi, Matteo Tacelli

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

Braden Kuo Braden Kuo, Artemis Trikola, Kyle Staller, Benjamin Glickman, Nir Bar

UEG Podcast Episode
UEG Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Mary Phillips, Leigh Donnelly

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Primary Care

Published

2025

More Like This:

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Leigh Donnelly Leigh Donnelly, Mary Phillips

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

Lumir Kunovsky Lumir Kunovsky, Alberto Zanetto, Jonas J. Staudacher, Sophie Schlosser-Hupf, Lucas Wauters, Andrei Mihai Voiosu, Katja Tepeš, Milica Stojkovic Lalosevic, Paula Sousa, Cem Simsek, Orestis Sidiropoulos, Maciej Salaga, Hasan Sadigov, Odri Qejvani, Anthea Pisani, Gianluca Pellino, Hassan Ouaya, Yana Nikiforova, Maria Moris, Mattias Mandorfer, Jan Král, Iris J. M. Levink, Henriette Heinrich, Ismar Hasukic, Valon Hamza, Amer Hadi, Zornitsa Gorcheva, Mark Enrik Geissler, Anne Fennessy, Omar Elshaarawy, Martin Ďuriček, Ana Dugic, Viktor Domislovic, Egle Dieninyte - Misiune, Helena Tammela, Myriam Ayari, Pilar Acedo, Marcus Hollenbach, Stavros Dimitriadis, Oscar Cahyadi, Karim Hamesch

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

Miguel Mascarenhas-Saraiva Miguel Mascarenhas-Saraiva, Rui Tato Marinho, Carina Leal, Joana Revés, Bárbara Morão, Joao Paulo Laranjeira Correia, João Carlos Silva, Paulo Souto, Mara Costa, Silvia Maria Barrias, Tiago Guedes, Helena Coelho Lima, Raquel R. Mendes, Jose Azevedo Rodrigues, André Mascarenhas

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

Gabriele Capurso Gabriele Capurso, Paolo Giorgio Arcidiacono, Caterina Stornello, Niccolò Bina, Camilla Gallo, Sara Massironi, Matteo Tacelli

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

Braden Kuo Braden Kuo, Artemis Trikola, Kyle Staller, Benjamin Glickman, Nir Bar

UEG Poster
Standard Poster
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

Karim Hamesch 1, Oscar Cahyadi 2, Stavros Dimitriadis 3, Marcus Hollenbach 4, Pilar Acedo 5, Myriam Ayari 6, Helena Tammela 7, Egle Dieninyte - Misiune 8, Viktor Domislovic 9, Ana Dugic 10, Martin Ďuriček 11, Omar Elshaarawy 12, Anne Fennessy 13, Mark Enrik Geissler 14, Zornitsa Gorcheva 15, Amer Hadi 16, Valon Hamza 17, Ismar Hasukic 18, Henriette Heinrich 19, Iris J. M. Levink 20, Jan Král 21, Lumir Kunovsky 22, Mattias Mandorfer 23, Maria Moris 24, Yana Nikiforova 25, Hassan Ouaya 26, Gianluca Pellino 27, Anthea Pisani 28, Odri Qejvani 29, Hasan Sadigov 30, Maciej Salaga 31, Orestis Sidiropoulos 32, Cem Simsek 33, Paula Sousa 34, Milica Stojkovic Lalosevic 35, Katja Tepeš 36, Andrei Mihai Voiosu 37, Lucas Wauters 38, Alberto Zanetto 39, Sophie Schlosser-Hupf 40, Jonas J. Staudacher 41

Affiliations

1 University Hospital Aachen, Aachen, Germany|||University Hospital RWTH Aachen, Aachen, Germany|||Junge Gastroenterologie (JuGa) - German Young Gastroenterology Study Group, Berlin, Germany

2 St. Josef-Hospital, a hospital of the Ruhr-University-Bochum, Essen, Germany|||Junge Gastroenterologie (JuGa) - German Young Gastroenterology Study Group, Berlin, Germany

3 University Hospital Coventry and Warwickshire, Coventry, United Kingdom|||Junge Gastroenterologie (JuGa) - German Young Gastroenterology Study Group, Berlin, Germany

4 Heidelberg University Hospital, Heidelberg, Germany|||Junge Gastroenterologie (JuGa) - German Young Gastroenterology Study Group, Berlin, Germany

5 University College London, London, United Kingdom

6 Internal Security Forces Hospital La Marsa, Tunis, Tunisia

7 East Tallinn Central Hospital, Tallinn, Estonia

8 Vilnius university Santaros Klinikos, Vilnius, Lithuania|||Vilnius university hospital Santara Clinics, Vilnius, Lithuania

9 University Hospital Centre Zagreb, Zagreb, Croatia

10 Heidelberg University Hospital, Department of Medicine IV, Heidelberg, Germany, Heidelberg, Germany|||Karolinska Institute, Stockholm, Sweden|||Junge Gastroenterologie (JuGa) - German Young Gastroenterology Study Group, Berlin, Germany

11 Jessenius Faculty of Medicine, University Hospital in Martin, Martin, Slovakia

12 Royal Liverpool University Hospital, UK, Liverpool, United Kingdom|||National Liver Institute, Menoufia University, Menoufia, Egypt

13 St Vincent's University Hospital, Dublin 14, Ireland

14 Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany|||Junge Gastroenterologie (JuGa) - German Young Gastroenterology Study Group, Berlin, Germany

15 Saint Marina University Hospital, Pleven, Bulgaria

16 Hvidovre University Hospital, Soeborg, Denmark

17 University Clinical Center of Kosova, Prishtine, Kosovo

18 UKC Tuzla, Tuzla, Bosnia and Herzegovina

19 Universitätsspital Basel, Basel, Switzerland

20 Erasmus University Medical Center, Rotterdam, Netherlands

21 Institute for Clinical and Experimental Medicine, Prague, Czechia|||Second Faculty of Medicine, Charles University, Prague, Czechia

22 2nd Department of Internal Medicine – Gastroenterology and Geriatrics, University Hospital Olomouc, Faculty of Medicine, Palacky University Olomouc, Olomouc, Czechia|||University Hospital Olomouc, Faculty of Medicine and Dentistry, Olomouc, Czechia|||Masa

23 Medical University of Vienna, Vienna, Austria

24 Hospital Universitario Marqués de Valdecilla, Santander, Spain

25 Government Institution “L.T.Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine”, Kharkov, Ukraine

26 tangier faculty of medicine / tangier mohamed VI university hospital, Tangier, Morocco

27 Università degli Studi della Campania "Luigi Vanvitelli", Aversa (CE), Italy|||Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona UAB, Barcelona, Spain

28 Mater Dei Hospital, Mosta, Malta

29 University Hospital Center 'Mother Teresa', Tirana, Albania

30 AZERBAIJAN MEDICAL UNIVERSITY, Baku, Azerbaijan

31 Medical University of Lodz, Lodz, Poland

32 417 NIMTS, Cholargos, Greece

33 Hacettepe University, Ankara, Turkey

34 Tondela-Viseu Hospital Center, Viseu, Portugal

35 Clinical center of Serbia, Belgrade, Serbia

36 Diagnostic center Rogaska, Rogaska Slatina, Slovenia

37 Colentina Clinical Hospital Dept. of Gastroenterology, Bucharest, Romania

38 University Hospitals Leuven, Leuven, Belgium

39 Gastroenterology/Multivisceral Transplant Unit, Padua, Italy

40 Universitätsklinikum Regensburg, Regensburg, Germany|||Junge Gastroenterologie (JuGa) - German Young Gastroenterology Study Group, Berlin, Germany

41 Charité Universitätsmedizin Berlin, Berlin, Germany|||Berlin Institute of Health at Charité, Berlin, Germany

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Endoscopic retrograde cholangiopancreatography (ERCP) remains the procedure with the highest complication rate underscoring the importance of high-quality training. Despite existing guidelines, real-world data regarding training conditions remain limited. This Pan-European survey aims to explore the perceptions surrounding ERCP training.

Aims & Methods

A survey was distributed through the friends of the Young United European Gastroenterologists (UEG) Talent Group network. Inclusion criteria were physicians working in a UEG member state and regularly performing ERCP. Likert-scales as well as single- and multiple-choice questions were utilized.

Results

649 of 1035 respondents from 35 countries were eligible for analysis. 228 were identified as trainees, 225 as trainers, and 196 regularly performed ERCP without being in either category. The mean age was 43 years with 72.0%, 27.6%, and 0.3% identifying as male, female, and non-binary, respectively. 73% of all participants agreed that a structured training regimen is desirable. However, 64% of participants reported not having such a structured program at their institution (71% of trainees and 55% of trainers). Likewise, 80% of participants did not have a mandatory self-assessment before training initiation.
Majority of trainees (73%) and trainers (81%) favored that training should be concentrated within centers meeting certain quality metrics. For this, 64% of all participants indicated that a threshold of 200 annual ERCPs should be used. Using this threshold revealed that 32% of trainees pursued training in centers with <200 annual ERCPs and that a low annual caseload of <50 was more frequent at lower volume centers vs. higher volume centers (86% vs. 63%, respectively). Furthermore, 71% of trainees performed <50 ERCPs/year in stark contrast to 95% of trainers performing >50 ERCPs/year. While 27% of trainees in higher volume centers were female, all trainees in lower volume centers were of female gender.

Conclusion

The first Pan-European survey investigating ERCP training conditions revealed that structured training and concentration of training efforts within European centers meeting specific quality metrics are desirable but exposed the low availability of structured training programs and that around 30% of trainees are practicing at lower volume centers. These data could be interpreted as motivation to further standardize ERCP training conditions and ultimately improve patient care throughout Europe.

Conference

UEG Week Vienna 2024

Topics

Hepatobiliary

Submission format

Abstract

Session

Endoscopic techniques (Posters)

Citation

United European Gastroenterology Journal 2024; 12 (Supplement 8)

Published

2024

More Like This:

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Leigh Donnelly Leigh Donnelly, Mary Phillips

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

Lumir Kunovsky Lumir Kunovsky, Alberto Zanetto, Jonas J. Staudacher, Sophie Schlosser-Hupf, Lucas Wauters, Andrei Mihai Voiosu, Katja Tepeš, Milica Stojkovic Lalosevic, Paula Sousa, Cem Simsek, Orestis Sidiropoulos, Maciej Salaga, Hasan Sadigov, Odri Qejvani, Anthea Pisani, Gianluca Pellino, Hassan Ouaya, Yana Nikiforova, Maria Moris, Mattias Mandorfer, Jan Král, Iris J. M. Levink, Henriette Heinrich, Ismar Hasukic, Valon Hamza, Amer Hadi, Zornitsa Gorcheva, Mark Enrik Geissler, Anne Fennessy, Omar Elshaarawy, Martin Ďuriček, Ana Dugic, Viktor Domislovic, Egle Dieninyte - Misiune, Helena Tammela, Myriam Ayari, Pilar Acedo, Marcus Hollenbach, Stavros Dimitriadis, Oscar Cahyadi, Karim Hamesch

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

Miguel Mascarenhas-Saraiva Miguel Mascarenhas-Saraiva, Rui Tato Marinho, Carina Leal, Joana Revés, Bárbara Morão, Joao Paulo Laranjeira Correia, João Carlos Silva, Paulo Souto, Mara Costa, Silvia Maria Barrias, Tiago Guedes, Helena Coelho Lima, Raquel R. Mendes, Jose Azevedo Rodrigues, André Mascarenhas

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

Gabriele Capurso Gabriele Capurso, Paolo Giorgio Arcidiacono, Caterina Stornello, Niccolò Bina, Camilla Gallo, Sara Massironi, Matteo Tacelli

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

Braden Kuo Braden Kuo, Artemis Trikola, Kyle Staller, Benjamin Glickman, Nir Bar

UEG Poster
Standard Poster
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

André Mascarenhas 1, Jose Azevedo Rodrigues 2, Raquel R. Mendes 1, Helena Coelho Lima 3, Tiago Guedes 4, Silvia Maria Barrias 4, Mara Costa 5, Paulo Souto 5, João Carlos Silva 6, Joao Paulo Laranjeira Correia 6, Bárbara Morão 7, Joana Revés 7, Carina Leal 8, Rui Tato Marinho 9, Miguel Mascarenhas-Saraiva 3

Affiliations

1 Unidade Local de Saúde de Lisboa Ocidental, Lisboa, Portugal

2 Unidade Local de Saúde de Lisboa Ocidental, Lisboa, Portugal|||Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal

3 ManopH, Porto, Portugal

4 Centro Hospitalar Universitário de Santo António, Porto, Portugal

5 Unidade Local de Saúde de Coimbra, Coimbra, Portugal

6 Unidade Local de Saúde Gaia e Espinho, Vila Nova de Gaia, Portugal

7 Hospital Beatriz Ângelo, Loures, Portugal

8 Unidade Local de Saúde de Leiria, Leiria, Portugal

9 Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal|||Unidade Local de Saúde de Santa Maria, Lisboa, Portugal

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Dysphagia is a common condition with consequences surpassing the physical dimension and extending to the patient’s psychological, personal, and professional life. However, when referring to non-obstructive esophageal dysphagia (NOD) and motility disorders, data is still scarce.

Aims & Methods

Our study consists in a prospective and multicentric evaluation of the severity of dysphagia and its impact on quality of life, that was measured with the Eckardt, EuroQol-5D (TTO and VAS) and PROMIS GI Disrupted Swallowing (PDS) scores, in patients with NOD and underlying motility disorders. We included 373 individuals (250 with NOD and 123 without dysphagia).

Results

Among patients with NOD, 97 had esophagogastric junction (EGJ) outflow disorders on manometry according to Chicago V4.0, 24 spastic motility disorders, 38 hypomotile disorders and 91 normal motility. Compared with non-dysphagic individuals, dysphagic patients had significantly worse scores of both EuroQol-5D and PDS (p-values <0.001).
Among esophageal motility disorders, Eckardt score was significantly different between groups (p-value <0.001) as determined by ANOVA. Specifically, it was significantly higher in EGJ outflow disorders (mean of 5.2), when compared to spastic motility disorders (mean of 3.3) or dysphagic patients with normal motility (mean of 3.2).
With respect to Patient-reported outcomes, PDS score was statistically different between groups (p-value 0.003), being higher in the EGJ outflow disorders (mean T-score of 64.1) when compared to hypomotiity disorders (mean of 60.2) and dysphagic patients with normal motility (mean of 60.3).
Regarding patient-reported quality of life, there were no differences between groups in terms of EuroQol-5D TTO or VAS score (p-value of 0.156 and 0.368, respectively).

Conclusion

Our findings highlights the impact of NOD on the quality-of-life of patients. Although physician and patient reported symptoms’ severity were worse on EGJ outflow disorders, overall quality of life seems equally affected among all esophageal motility profiles.

Conference

UEG Week Vienna 2024

Topics

Oesophagus

Submission format

Abstract

Session

OESOPHAGEAL, GASTRIC AND DUODENAL (Posters)

Citation

United European Gastroenterology Journal 2024; 12 (Supplement 8)

Published

2024

More Like This:

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Leigh Donnelly Leigh Donnelly, Mary Phillips

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

Lumir Kunovsky Lumir Kunovsky, Alberto Zanetto, Jonas J. Staudacher, Sophie Schlosser-Hupf, Lucas Wauters, Andrei Mihai Voiosu, Katja Tepeš, Milica Stojkovic Lalosevic, Paula Sousa, Cem Simsek, Orestis Sidiropoulos, Maciej Salaga, Hasan Sadigov, Odri Qejvani, Anthea Pisani, Gianluca Pellino, Hassan Ouaya, Yana Nikiforova, Maria Moris, Mattias Mandorfer, Jan Král, Iris J. M. Levink, Henriette Heinrich, Ismar Hasukic, Valon Hamza, Amer Hadi, Zornitsa Gorcheva, Mark Enrik Geissler, Anne Fennessy, Omar Elshaarawy, Martin Ďuriček, Ana Dugic, Viktor Domislovic, Egle Dieninyte - Misiune, Helena Tammela, Myriam Ayari, Pilar Acedo, Marcus Hollenbach, Stavros Dimitriadis, Oscar Cahyadi, Karim Hamesch

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

Miguel Mascarenhas-Saraiva Miguel Mascarenhas-Saraiva, Rui Tato Marinho, Carina Leal, Joana Revés, Bárbara Morão, Joao Paulo Laranjeira Correia, João Carlos Silva, Paulo Souto, Mara Costa, Silvia Maria Barrias, Tiago Guedes, Helena Coelho Lima, Raquel R. Mendes, Jose Azevedo Rodrigues, André Mascarenhas

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

Gabriele Capurso Gabriele Capurso, Paolo Giorgio Arcidiacono, Caterina Stornello, Niccolò Bina, Camilla Gallo, Sara Massironi, Matteo Tacelli

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

Braden Kuo Braden Kuo, Artemis Trikola, Kyle Staller, Benjamin Glickman, Nir Bar

UEG Poster
Standard Poster
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

Matteo Tacelli 1, Sara Massironi 2, Camilla Gallo 2, Niccolò Bina 1, Caterina Stornello 1, Paolo Giorgio Arcidiacono 1, Gabriele Capurso 1

Affiliations

1 San Raffaele Scientific Institute IRCCS, Milano, Italy

2 Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) are heterogeneous tumors, with multiple therapeutic options for advanced stages. The combination of capecitabine and temozolomide (CAPTEM) is increasingly used for advanced GEP-NEN, but evidence on results is sparse.

Aims & Methods

We conducted a systematic review and meta-analysis to assess efficacy and safety of CAPTEM in advanced GEP-NEN. We included studies enrolling patients with any grade GEP-NENs undergoing CAPTEM. A meta-analysis with random effects model, progression-free survival (PFS) as primary endpoint and severe adverse events (SAEs) rate as secondary endpoint was performed. Different treatment schedules were considered. The heterogeneity (I2) was interpreted by metaregression analysis considering the following covariates: study type and design, sample size, metastatic disease rate, rate of primary pancreatic NENs, previous treatments, and study quality.

Results

A total of 22 studies with 788 patients (age range 29-64 years; male proportion range 46.9-65%, primary pancreatic site range 14-100%) were included. All but 1 study, being a RCT, were retrospective. The median CAPTEM cycles number was 6.9 (IQR 4.5-8). The cumulative PFS was 14.7 months (12.9-16.5), with high heterogeneity (I2=99%). Study type and design, previous treatments, and quality of the studies did not affect PFS. Although not significant, PFS was higher in patients with nonpancreatic primary tumors and in post-2017 trials. The pooled SAEs rate was 17.6% (10.1-25). There was no publication bias.

Conclusion

CAPTEM is an effective combination, with similar PFS and a safety profile compared to other agents. Further investigation in RCTs or in sequence studies is advisable.

Disclosure

No disclosures

Conference

UEG Week Copenhagen 2023

Topics

Pancreas

Submission format

Abstract

Session

PP 08 Pancreas (Posters)

Citation

United European Gastroenterology Journal 2023; 11 (Supplement 8)

Published

2023

More Like This:

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Leigh Donnelly Leigh Donnelly, Mary Phillips

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

Lumir Kunovsky Lumir Kunovsky, Alberto Zanetto, Jonas J. Staudacher, Sophie Schlosser-Hupf, Lucas Wauters, Andrei Mihai Voiosu, Katja Tepeš, Milica Stojkovic Lalosevic, Paula Sousa, Cem Simsek, Orestis Sidiropoulos, Maciej Salaga, Hasan Sadigov, Odri Qejvani, Anthea Pisani, Gianluca Pellino, Hassan Ouaya, Yana Nikiforova, Maria Moris, Mattias Mandorfer, Jan Král, Iris J. M. Levink, Henriette Heinrich, Ismar Hasukic, Valon Hamza, Amer Hadi, Zornitsa Gorcheva, Mark Enrik Geissler, Anne Fennessy, Omar Elshaarawy, Martin Ďuriček, Ana Dugic, Viktor Domislovic, Egle Dieninyte - Misiune, Helena Tammela, Myriam Ayari, Pilar Acedo, Marcus Hollenbach, Stavros Dimitriadis, Oscar Cahyadi, Karim Hamesch

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

Miguel Mascarenhas-Saraiva Miguel Mascarenhas-Saraiva, Rui Tato Marinho, Carina Leal, Joana Revés, Bárbara Morão, Joao Paulo Laranjeira Correia, João Carlos Silva, Paulo Souto, Mara Costa, Silvia Maria Barrias, Tiago Guedes, Helena Coelho Lima, Raquel R. Mendes, Jose Azevedo Rodrigues, André Mascarenhas

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

Gabriele Capurso Gabriele Capurso, Paolo Giorgio Arcidiacono, Caterina Stornello, Niccolò Bina, Camilla Gallo, Sara Massironi, Matteo Tacelli

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

Braden Kuo Braden Kuo, Artemis Trikola, Kyle Staller, Benjamin Glickman, Nir Bar

UEG Poster
Standard Poster
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

Nir Bar 1, Benjamin Glickman 2, Kyle Staller 2, Artemis Trikola 2, Braden Kuo 2

Affiliations

1 Massachusetts General Hospital, Boston, Israel

2 Massachusetts General Hospital, Boston, United States

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Introduction

High resolution esophageal manometry (HRM) is commonly used to assess esophageal motility disorders. Data about the effect of age on HRM parameters and diagnoses are contradictory.

Aims & Methods

We aimed to explore the effect of age on HRM parameters and diagnoses in those under and above the age of 65.
We included all patients undergoing HRM within our institution between 2020-2021 (across both Chicago Classification 3 and 4 protocols). Clinically relevant esophagogastric junction outflow obstruction (EJGOO) was defined as having dysphagia or chest pain, elevated integrated relaxation pressure (IRP) in both positions where available, and positive adjunctive tests. Adjunctive tests included timed barium esophagrams, esophagram with a barium tablet, and/or functional lumen imaging probe (FLIP) tests.

Results

Of 486 included patients, 59% were female patients, 81% white, 3% Hispanic. There were 151 (31%) aged 65 and older and 335 (69%) younger than 65. The age≥65 vs. under 65 groups had similar proportions of female patients (61% vs.58%), race and ethnicity distribution, though older patients had lower median (IQR) BMI (26 [23-30] vs. 27 [24-31], p=0.023)
The age≥65 group had a higher IRP and mean lower esophageal sphincter pressure (LES) compared to the age<65 group, p<0.01 for both. Additionally, patients older than 65 had a higher rate of both manometric and clinically relevant EGJOO (p<0.001 for both), and a lower rate of hypomotility diagnoses. See table for details.
Multivariable logistic regression showed that age was independently associated with EGJOO per CC3 (elevated IRP in at least one position [upright or supine] and normal peristalsis): OR= 1.72 (95% CI 1.35-2.19, p<0.001) for each 10-year increase in age and after adjusting for sex, BMI and the study protocol (Chicago 3 or 4). Furthermore, within the group of patients with EGJOO per CC3, the odds of being diagnosed with clinically relevant EGJOO were 4.28 (95% CI 1.34-13.7, p=0.014) for each 10-year increase in age and adjusting for the same variables.


Total Cohort n=486
Younger than 65 n=335
65 and older
n=151
P vlaue
Mean LES pressure (mmHg)26.1 (15.7 - 39.3)25 (14.2 - 36.5)29.1 (17.8 - 43.5)0.004
Median IRP (mmHg)9 (4.8 - 14.4)8.5 (4.2 - 13.3)10.7 (5.9 - 18.2)<0.001
Normal peristalsis %79.5 (33 - 100)75 (30 - 100)80 (40 - 100)NS
Ineffective %20 (0 - 62)20 (0 - 67)14 (0 - 54)NS
Hypomotility disorders (Absent contractility or Ineffective motility)
106 (22%)82 (25%)24 (16%)0.034
Hypermotility disorders:
104 (21%)53 (16%)51 (34%)<0.001
Achalasia26 (5%)15 (5%)9 (6%)NS
Manometric EGJOO68 (14%)29 (9%)39 (26%)<0.001
Clinically relevant (symptomatic, Manometric and positive barium swallow tests)19 (4%)
4 (1%)

29 (26%)

<0.001

Conclusion

Our data show that HRM results differ in patients referred for manometry and older than 65. Specifically, these patients have a higher rate of clinically relevant EJGOO and greater IRP. This may be related to age related changes in myenteric innervation. Future studies are needed to establish whether patients older than 65 progress to achalasia or will benefit from EGJ directed therapy.

Conference

UEG Week Copenhagen 2023

Topics

Oesophagus

Submission format

Abstract

Session

PP 01 Oesophageal, gastric and duodenal disorders (Posters)

Citation

United European Gastroenterology Journal 2023; 11 (Supplement 8)

Published

2023

More Like This:

Management of early-invasive (T1) colorectal cancer

Management of early-invasive (T1) colorectal cancer

James Hardwick James Hardwick, Jurjen J. Boonstra, Alexandra Langers

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly

Leigh Donnelly Leigh Donnelly, Mary Phillips

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

BETWEEN VISION AND REALITY: RESULTS FROM A PAN-EUROPEAN SURVEY ON ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY TRAINING CONDITIONS

Lumir Kunovsky Lumir Kunovsky, Alberto Zanetto, Jonas J. Staudacher, Sophie Schlosser-Hupf, Lucas Wauters, Andrei Mihai Voiosu, Katja Tepeš, Milica Stojkovic Lalosevic, Paula Sousa, Cem Simsek, Orestis Sidiropoulos, Maciej Salaga, Hasan Sadigov, Odri Qejvani, Anthea Pisani, Gianluca Pellino, Hassan Ouaya, Yana Nikiforova, Maria Moris, Mattias Mandorfer, Jan Král, Iris J. M. Levink, Henriette Heinrich, Ismar Hasukic, Valon Hamza, Amer Hadi, Zornitsa Gorcheva, Mark Enrik Geissler, Anne Fennessy, Omar Elshaarawy, Martin Ďuriček, Ana Dugic, Viktor Domislovic, Egle Dieninyte - Misiune, Helena Tammela, Myriam Ayari, Pilar Acedo, Marcus Hollenbach, Stavros Dimitriadis, Oscar Cahyadi, Karim Hamesch

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

IMPACT OF NON-OBSTRUCTIVE ESOPHAGEAL DYSPHAGIA ON QUALITY OF LIFE: A PORTUGUESE MULTICENTRIC PROSPECTIVE STUDY

Miguel Mascarenhas-Saraiva Miguel Mascarenhas-Saraiva, Rui Tato Marinho, Carina Leal, Joana Revés, Bárbara Morão, Joao Paulo Laranjeira Correia, João Carlos Silva, Paulo Souto, Mara Costa, Silvia Maria Barrias, Tiago Guedes, Helena Coelho Lima, Raquel R. Mendes, Jose Azevedo Rodrigues, André Mascarenhas

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

EFFICACY AND SAFETY OF CAPECITABINE AND TEMOZOLOMIDE (CAPTEM) IN ADVANCED GASTRO-ENTERO-PANCREATIC NEUROENDOCRINE NEOPLASMS (GEP-NEN): A SYSTEMATIC REVIEW AND METANALYSIS

Gabriele Capurso Gabriele Capurso, Paolo Giorgio Arcidiacono, Caterina Stornello, Niccolò Bina, Camilla Gallo, Sara Massironi, Matteo Tacelli

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

PATIENTS WHO ARE OLDER THAN 65 HAVE HIGHER RATES OF CLINICALLY RELEVANT ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION AND HIGHER INTEGRATED RELAXATION PRESSURES

Braden Kuo Braden Kuo, Artemis Trikola, Kyle Staller, Benjamin Glickman, Nir Bar

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

support@ueg.eu

ueg.eu

T: +43 1 997 1639

Legal

Terms & Conditions

Imprint

Privacy Policy

Explore

My Bookmarks

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.
Click the item to unselect it. You can select multiple items.